List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Pancreatic Endocrine Tumor Drug Product Introduction
1.2 Global Pancreatic Endocrine Tumor Drug Outlook 2017 VS 2022 VS 2028
1.2.1 Global Pancreatic Endocrine Tumor Drug Sales in US$ Million for the Year 2017-2028
1.2.2 Global Pancreatic Endocrine Tumor Drug Sales in Volume for the Year 2017-2028
1.3 United States Pancreatic Endocrine Tumor Drug Outlook 2017 VS 2022 VS 2028
1.3.1 United States Pancreatic Endocrine Tumor Drug Sales in US$ Million for the Year 2017-2028
1.3.2 United States Pancreatic Endocrine Tumor Drug Sales in Volume for the Year 2017-2028
1.4 Pancreatic Endocrine Tumor Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Pancreatic Endocrine Tumor Drug in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Pancreatic Endocrine Tumor Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Pancreatic Endocrine Tumor Drug Market Dynamics
1.5.1 Pancreatic Endocrine Tumor Drug Industry Trends
1.5.2 Pancreatic Endocrine Tumor Drug Market Drivers
1.5.3 Pancreatic Endocrine Tumor Drug Market Challenges
1.5.4 Pancreatic Endocrine Tumor Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Pancreatic Endocrine Tumor Drug Market Segment by Type
2.1.1 Buparlisib Hydrochloride
2.1.2 Dovitinib Lactate
2.1.3 Fosbretabulin Tromethamine
2.1.4 Lanreotide Acetate
2.1.5 MPHE-001B
2.1.6 Others
2.2 Global Pancreatic Endocrine Tumor Drug Market Size by Type
2.2.1 Global Pancreatic Endocrine Tumor Drug Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Pancreatic Endocrine Tumor Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Pancreatic Endocrine Tumor Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Pancreatic Endocrine Tumor Drug Market Size by Type
2.3.1 United States Pancreatic Endocrine Tumor Drug Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Pancreatic Endocrine Tumor Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Pancreatic Endocrine Tumor Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Pancreatic Endocrine Tumor Drug Market Segment by Application
3.1.1 Clinic
3.1.2 Research Center
3.1.3 Hospital
3.2 Global Pancreatic Endocrine Tumor Drug Market Size by Application
3.2.1 Global Pancreatic Endocrine Tumor Drug Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Pancreatic Endocrine Tumor Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Pancreatic Endocrine Tumor Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Pancreatic Endocrine Tumor Drug Market Size by Application
3.3.1 United States Pancreatic Endocrine Tumor Drug Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Pancreatic Endocrine Tumor Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Pancreatic Endocrine Tumor Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Pancreatic Endocrine Tumor Drug Competitor Landscape by Company
4.1 Global Pancreatic Endocrine Tumor Drug Market Size by Company
4.1.1 Top Global Pancreatic Endocrine Tumor Drug Manufacturers Ranked by Revenue (2021)
4.1.2 Global Pancreatic Endocrine Tumor Drug Revenue by Manufacturer (2017-2022)
4.1.3 Global Pancreatic Endocrine Tumor Drug Sales by Manufacturer (2017-2022)
4.1.4 Global Pancreatic Endocrine Tumor Drug Price by Manufacturer (2017-2022)
4.2 Global Pancreatic Endocrine Tumor Drug Concentration Ratio (CR)
4.2.1 Pancreatic Endocrine Tumor Drug Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pancreatic Endocrine Tumor Drug in 2021
4.2.3 Global Pancreatic Endocrine Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Pancreatic Endocrine Tumor Drug Manufacturing Base Distribution, Product Type
4.3.1 Global Pancreatic Endocrine Tumor Drug Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Pancreatic Endocrine Tumor Drug Product Type
4.3.3 Date of International Manufacturers Enter into Pancreatic Endocrine Tumor Drug Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Pancreatic Endocrine Tumor Drug Market Size by Company
4.5.1 Top Pancreatic Endocrine Tumor Drug Players in United States, Ranked by Revenue (2021)
4.5.2 United States Pancreatic Endocrine Tumor Drug Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Pancreatic Endocrine Tumor Drug Sales by Players (2020, 2021 & 2022)
5 Global Pancreatic Endocrine Tumor Drug Market Size by Region
5.1 Global Pancreatic Endocrine Tumor Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Pancreatic Endocrine Tumor Drug Market Size in Volume by Region (2017-2028)
5.2.1 Global Pancreatic Endocrine Tumor Drug Sales in Volume by Region: 2017-2022
5.2.2 Global Pancreatic Endocrine Tumor Drug Sales in Volume Forecast by Region (2023-2028)
5.3 Global Pancreatic Endocrine Tumor Drug Market Size in Value by Region (2017-2028)
5.3.1 Global Pancreatic Endocrine Tumor Drug Sales in Value by Region: 2017-2022
5.3.2 Global Pancreatic Endocrine Tumor Drug Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Pancreatic Endocrine Tumor Drug Market Size YoY Growth 2017-2028
6.1.2 North America Pancreatic Endocrine Tumor Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Pancreatic Endocrine Tumor Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Pancreatic Endocrine Tumor Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Pancreatic Endocrine Tumor Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Pancreatic Endocrine Tumor Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Pancreatic Endocrine Tumor Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Pancreatic Endocrine Tumor Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Pancreatic Endocrine Tumor Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Pancreatic Endocrine Tumor Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Ipsen S.A.
7.1.1 Ipsen S.A. Corporation Information
7.1.2 Ipsen S.A. Description and Business Overview
7.1.3 Ipsen S.A. Pancreatic Endocrine Tumor Drug Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Ipsen S.A. Pancreatic Endocrine Tumor Drug Products Offered
7.1.5 Ipsen S.A. Recent Development
7.2 Jiangsu Hengrui Medicine Co., Ltd.
7.2.1 Jiangsu Hengrui Medicine Co., Ltd. Corporation Information
7.2.2 Jiangsu Hengrui Medicine Co., Ltd. Description and Business Overview
7.2.3 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Products Offered
7.2.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Development
7.3 MediaPharma s.r.l.
7.3.1 MediaPharma s.r.l. Corporation Information
7.3.2 MediaPharma s.r.l. Description and Business Overview
7.3.3 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Sales, Revenue and Gross Margin (2017-2022)
7.3.4 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Products Offered
7.3.5 MediaPharma s.r.l. Recent Development
7.4 Novartis AG
7.4.1 Novartis AG Corporation Information
7.4.2 Novartis AG Description and Business Overview
7.4.3 Novartis AG Pancreatic Endocrine Tumor Drug Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Novartis AG Pancreatic Endocrine Tumor Drug Products Offered
7.4.5 Novartis AG Recent Development
7.5 OXiGENE, Inc.
7.5.1 OXiGENE, Inc. Corporation Information
7.5.2 OXiGENE, Inc. Description and Business Overview
7.5.3 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Sales, Revenue and Gross Margin (2017-2022)
7.5.4 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Products Offered
7.5.5 OXiGENE, Inc. Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Pancreatic Endocrine Tumor Drug Industry Chain Analysis
8.2 Pancreatic Endocrine Tumor Drug Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Pancreatic Endocrine Tumor Drug Distributors
8.3 Pancreatic Endocrine Tumor Drug Production Mode & Process
8.4 Pancreatic Endocrine Tumor Drug Sales and Marketing
8.4.1 Pancreatic Endocrine Tumor Drug Sales Channels
8.4.2 Pancreatic Endocrine Tumor Drug Distributors
8.5 Pancreatic Endocrine Tumor Drug Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
